A multicenter phase II randomized study of gemcitabine (G) weekly followed by erlotinib (E) after progression versus E followed by G after progression in advanced non-small cell lung cancer (NSCLC) in vulnerable elderly patients selected with a comprehensive geriatric assessment (CGA) (GFPC*0505).

Randomized Study ◽

Small Cell ◽

Small Cell Lung ◽

Multicenter Phase ◽

Vulnerable Elderly

A multicenter phase II randomized study of docetaxel (D)/gemcitabine (G) weekly followed by erlotinib (E) after progression versus erlotinib followed by docetaxel/gemcitabine after progression in advanced non-small cell lung cancer (NSCLC) in fit elderly patients selected with a comprehensive geriatric assessment (CGA): Groupe Français de Pneumocancerologie (GFPC)*0504.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7536 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7536-7536

Author(s):

H. Le Caer ◽

F. Barlesi ◽

R. Corre ◽

H. Jullian ◽

S. Bota ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Phase Ii ◽

Randomized Study ◽

Small Cell ◽

Small Cell Lung ◽

Multicenter Phase

P66 A multicenter phase II randomized study of docetaxel/gemcitabine weekly followed by erlotinib after progression versus erlotinib followed by docetaxel/gemcitabine after progression in advanced non small cell lung cancer (NSCLC) in fit elderly patients selected with a comprehensive geriatric assessment (CGA) (gfpc*0504): preliminary results

Critical Reviews in Oncology/Hematology ◽

10.1016/s1040-8428(09)70104-0 ◽

2009 ◽

Vol 72 (1) ◽

pp. S42

Author(s):

H. Le Caer ◽

F. Barlesi ◽

R. Corre ◽

H. Jullian ◽

D. Balas ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Phase Ii ◽

Randomized Study ◽

Small Cell ◽

Small Cell Lung ◽

Multicenter Phase

A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)

Lung Cancer ◽

10.1016/j.lungcan.2012.02.004 ◽

2012 ◽

Vol 77 (1) ◽

pp. 97-103 ◽

Cited By ~ 14

Author(s):

H. LeCaer ◽

L. Greillier ◽

R. Corre ◽

H. Jullian ◽

J. Crequit ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Randomized Trial ◽

Small Cell ◽

Small Cell Lung ◽

Multicenter Phase ◽

Reverse Sequence ◽

Vulnerable Elderly

Faculty Opinions recommendation of Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726151262.793518485 ◽

2016 ◽

Author(s):

Maria-José Molina-Garrido

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Faculty Opinions recommendation of Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726151262.793519511 ◽

2016 ◽

Author(s):

Theodora Karnakis

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Faculty Opinions recommendation of Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726151262.793552776 ◽

2018 ◽

Author(s):

Noelle LoConte ◽

Kieran Sahasrabudhe

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Comprehensive geriatric assessment and traditional Chinese medicine intervention benefit symptom control in elderly patients with advanced non-small cell lung cancer

Medical Oncology ◽

10.1007/s12032-015-0563-5 ◽

2015 ◽

Vol 32 (4) ◽

Cited By ~ 11

Author(s):

Dong Xue ◽

Shuyan Han ◽

Shantong Jiang ◽

Hong Sun ◽

Yanzhi Chen ◽

...

Keyword(s):

Lung Cancer ◽

Chinese Medicine ◽

Traditional Chinese Medicine ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Symptom Control ◽

Small Cell ◽

First Line Chemotherapy with Weekly Docetaxel and Cisplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer: A Multicenter Phase II Study

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181991d38 ◽

2009 ◽

Vol 4 (4) ◽

pp. 512-517 ◽

Cited By ~ 3

Author(s):

Keqi Han ◽

Weiguo Cao ◽

Jinfeng Che ◽

Shenxu Bo ◽

Xiaodong Guo ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Weekly Docetaxel ◽

Multicenter Phase ◽

Line Chemotherapy

ESOGIA: a “first step” for comprehensive geriatric assessment-guided treatment in non-small cell lung cancer

Translational Cancer Research ◽

10.21037/tcr.2016.07.33 ◽

2016 ◽

Vol 5 (S2) ◽

pp. S371-S373

Author(s):

Romain Corre ◽

Christos Chouaïd

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Cell Lung Cancer ◽

Small Cell ◽

Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the “polmone toscano group” (POLTO)

Lung Cancer ◽

10.1016/j.lungcan.2004.10.008 ◽

2005 ◽

Vol 48 (1) ◽

pp. 121-127 ◽

Cited By ~ 8

Author(s):

C. Tibaldi ◽

S. Ricci ◽

F. Russo ◽

I. Bernardini ◽

L. Galli ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Dose Intensity ◽

Small Cell ◽

Small Cell Lung ◽

Multicenter Phase